Cameron Meaney

Cameron Meaney

Scientist I
Quantitative Systems Pharmacology

Cameron Meaney, Ph.D.
Scientist I
Quantitative Systems Pharmacology

About Cameron
Cameron Meaney began as a summer intern with Simulations Plus in 2022 and is now a Scientist I. In his role, he works primarily in developing and maintaining SLP’s immuno-oncology models in the Thales platform, having worked on several of the current models. He previously has been involved with DILIsym projects through the development of SimPops to assess interpatient variability in adaptive immune responses and through creating PBPK models of exemplar compounds for use in the BIOLOGXsym software.

Cameron completed his Ph.D. in the Department of Applied Mathematics at the University of Waterloo. His research focused on mathematical oncology, specifically in using differential equations and machine learning models to personalize modern cancer treatments.

Latest DILIsym Services Research